Stock information

¥**** +***% +****

Volume: **** million

Turnover: *** billion

Total market value: *** billion

Market capitalization: ** billion

****年*月**日 **** Real-time information

Hongbin Sun

Independent Non-executive Director

Mr.Sun was appointed as our independent non-executive Director in 2019. Mr. Sun holds various positions in China Pharmaceutical University. He is currently a professor, director of the Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, and an associate director of the State Key Laboratory of Natural Medicines, of China Pharmaceutical University. Mr. Sun is also a distinguished professor under the Chang Jiang Scholars Programme administered by the Ministry of Education of the PRC, deputy head of the Pharmacology Expert Group established under the 13th Five-year Plan Research on Development Strategies of the Medicines Division of the National Natural Science Foundation of China and a member of the medicinal chemistry committee of the China Pharmaceutical Association.


Mr. Sun received a doctor’s degree in science from China Pharmaceutical University in the PRC in July 1995. During the period from 1995 to 2001, Mr. Sun conducted his postdoctoral research in Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, RWTH Aachen University in Germany, and University of Florida in the United States.


Mr. Sun is currently an independent director of Zhejiang Jianfeng Group Co. Ltd, a company listed on the Shanghai Stock Exchange (stock code: 600668).


Copyright © 2022 GHW International All Right Reserved | 苏ICP备05031427号-1